Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism JNK stimulants(c-Jun N-terminal kinase stimulants), Mcl-1 inhibitors(Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitors), Proto-oncogene proteins c-akt inhibitors(Proto-oncogene proteins c-akt inhibitors) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
acute leukemia | Preclinical | CN | 25 Apr 2017 |